TRACE2: Real-World Healthcare Costs for Head and Neck Cancer in Portugal

150 patient records from a retrospective cohort study in four Portuguese hospitals, covering diagnoses from June 2016 to May 2018. The dataset describes clinical characteristics, healthcare resource utilization, and direct medical costs for locally advanced head and neck squamous cell carcinoma. It was authored by Maria Margarida Teixeira and published on figshare in May 2026.

Use Cases

• Modeling treatment costs based on the reported median annualized cost per patient of €7,706.0.
• Analyzing healthcare resource utilization patterns for outpatient consultations, hospitalizations, and emergency visits.
• Studying the prevalence of risk factors like tobacco and heavy alcohol use within a specific patient cohort.
• Comparing the frequency of different treatment modalities such as combined systemic therapy and radiotherapy versus surgery.

Strengths

• Data covers 150 patients with detailed clinical and demographic characteristics, including a 94.7% male cohort.
• Provides a median annualized cost per patient figure (€7,706.0) with interquartile range, offering a concrete economic measure.
• Study design includes a defined time range for patient diagnosis (2016-2018) and follow-up until 2020.

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment.
• Data may reflect geographic and temporal bias inherent to its collection from four Portuguese hospitals over a specific period.

Provenance

Source

figshare

Collection Method

Non-interventional, retrospective cohort study using secondary data collected from medical records in four Portuguese hospitals.

Time Range

Patient diagnoses from 01/06/2016 to 31/05/2018, with follow-up data collected until 31/12/2020.

Freshness

Last updated 2026-05-29 06:43:52; freshness should be verified.

Geography

Portugal